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Abstract To facilitate the study of the mechanism of K-
latrotoxin action, it is necessary to create a biologically active
recombinant toxin. Mature K-latrotoxin is naturally produced by
post-translational cleavage, probably at two furin sites located at
the N- and C-termini of the precursor. A recombinant
baculovirus has now been constructed, which encodes the melittin
signal peptide fused to the 130-kDa mature toxin between the
furin sites. Insect cells, infected with this baculovirus, secreted
recombinant K-latrotoxin. This was partially purified and proved
indistinguishable from the natural toxin with respect to its
molecular mass, immunostaining, toxicity to mice, binding to
K-latrotoxin receptors (latrophilin or neurexin IK) and electro-
physiological recording in the mouse diaphragm. The successful
expression of recombinant K-latrotoxin permits mutational
analysis of the toxin.
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1. Introduction
K-Latrotoxin (K-LTX) is a protein neurotoxin from the
black widow spider venom that causes an exhaustive release
of neurotransmitters from nerve terminals and endocrine cells
in vertebrates [1^3]. This makes K-LTX an important natural
tool to study exocytosis. However, due to regional and sea-
sonal variability of the venom composition and because some
peptides from the venom co-purify with the toxin [4], K-LTX
e¡ects may vary between preparations. It is possible to over-
come these problems by producing a recombinant K-LTX.
This would also allow for mutational analysis of the toxin,
thus facilitating the study of its mechanism of action.
Production of the active, soluble K-LTX and its homo-
logues in bacteria proved very di⁄cult due to incorrect pro-
tein folding ([5] and data not shown). Attempts had also been
made to express K-LTX and K-latroinsectotoxin precursors in
a baculovirus system, but the proteins synthesised appeared
non-functional and insoluble [6].
This paper presents a reliable method for functional expres-
sion and puri¢cation of the mature, active form of K-LTX,
using an alternative strategy of the toxin production in bacu-
lovirus system.
2. Materials and methods
2.1. Generation of recombinant baculovirus
Overlapping plasmids pT-4N and pT-3C [7], covering the complete
K-LTX cDNA, were digested respectively with BamHI/EcoRI and
EcoRI/HpaII endonucleases and ligated into a pBlueScript vector
(Stratagene) cut with BamHI/AccI. This construct was used as a tem-
plate in a polymerase chain reaction (PCR) with primers (L01,
5P-TTGGGATCCGAAGGAGAAGATTTAACT-3P ; L08R, 5P-GA-
ACCGTCGACTTACCTCCGAAATTTTCCGCT-3P) that intro-
duced BamHI and SalI restriction sites, respectively, and the resulting
fragment was subcloned in frame with the melittin signal peptide of
the baculovirus transfer vector pMelBacA (Invitrogen) cut with the
same enzymes. Sf9 cells were cultured in complete TNM-FH medium
(Invitrogen) and co-transfected with this construct and the viral DNA
(Bac-N-Blue kit, Invitrogen). The medium above transfected cells was
tested by plaque assay, and blue recombinant plaques were selected.
Recombinant baculoviruses AcMNPv-K-LTX-M were ampli¢ed and
their purity was con¢rmed by PCR using proprietary primers (Invi-
trogen). High-titre, pure viral stocks were obtained after two addi-
tional rounds of ampli¢cation.
2.2. Expression and puri¢cation of K-LTX
For large-scale expression, Hi5 cells were cultured in Express Five
serum-free medium. Cells were plated at a density of 15U106 cells per
150-cm2 £ask and then infected with AcMNPv-K-LTX-M baculovirus
at a multiplicity of infection (MOI) of 10 pfu/cell. The medium was
replaced 24 h after infection; the new medium was harvested 72 h
later, adjusted to pH 8.2 using 1 M Tris base, clari¢ed by centrifuga-
tion at 5000Ug for 15 min and ¢ltered through a 0.22 Wm ¢lter
(Whatman). The medium (200 ml) was diluted 5 times with 25 mM
Tris-HCl, pH 8.2 (bu¡er A), and passed through a Q 15 anion-ex-
change ¢lter (Sartorius). The ¢lter was washed with 200 ml of bu¡er
A and eluted with 2 ml of bu¡er A supplemented with 1 M NaCl. The
eluate was immediately diluted to 20 ml with bu¡er A and loaded
onto a Mono-Q column (Pharmacia) equilibrated in bu¡er A contain-
ing 0.1 M NaCl. The column was eluted with a linear gradient of
NaCl (0.1^0.5 M) in the same bu¡er. Fractions obtained during the
chromatography were analysed by SDS-electrophoresis and Western
blotting. Fractions containing the recombinant K-LTX were dia¢l-
tered and concentrated in a Centricon unit (Amicon).
2.3. Electrophysiological experiments
Intracellular recordings of spontaneous miniature endplate poten-
tials (MEPPs) were made using conventional microelectrodes on a
mouse diaphragm, which was perfused with normal saline of the fol-
lowing composition (in mM): NaCl, 135; KCl, 4; NaH2PO4, 0.9;
MgCl2, 1; CaCl2, 3.6; NaHCO3, 16.3; glucose, 11; pH 7.2^7.4.
Traces were stored on magnetic tape and subsequently processed elec-
tronically.
2.4. Expression of K-LTX receptors in COS-7 cells and binding
experiments
COS-7 (gift from C. Isacke) cells were grown at 5% CO2 in stand-
ard DMEM supplemented with 10% foetal calf serum, 2 mM glut-
amine and antibiotics (Gibco). Latrophilin [8] or neurexin IK [9]
cDNAs were subcloned into pcDNA3.1 vector (Invitrogen) under
the control of the CMV promoter. These constructs were introduced
into exponentially growing COS cells using the SuperFect transfection
reagent (Qiagen). The cells were harvested 24 h after transfection and
washed several times with PBS by centrifugation for 10 min at
1000Ug. The cells were then resuspended in the Hi5 medium contain-
ing secreted recombinant K-LTX (1U106 cells/200 Wl), incubated for
10 min at room temperature and pelleted by centrifugation. The pel-
lets were analysed by SDS-gel electrophoresis and Western blotting
using a monoclonal anti-K-LTX antibody YaL-1 (gift from V. Pash-
kov).
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3. Results and discussion
3.1. Construction of recombinant baculovirus
The molecular mass of K-LTX deduced from the cDNA is
156.9 kDa [7]. However, based on SDS electrophoresis [10]
and MALDI mass spectrometry (I. Dulubova and T. Chait,
personal communication), the molecular mass of the toxin
puri¢ed from the venom is signi¢cantly smaller (about 131
kDa). It is reasonable to suggest that K-LTX is synthesised
as a larger precursor, which is cleaved post-translationally.
This modi¢cation may be required for the toxin activation.
Indeed, expression of the full-length K-LTX in insect cells
resulted in a functionally inert protein [6]. The N-terminus
of mature K-LTX has been experimentally determined [11].
Surprisingly, it is preceded not by a de¢ned signal peptide
but by amino acids R-M-R-R, which constitute the recogni-
tion site (R-X-R/K-R) of furin, a subtilisin-like proteolytic
enzyme involved in the processing of many protein precursors
[12]. Furin has been shown to cleave and activate, among
other proteins, such toxins as Shiga toxin [13], Clostridium
septicum K-toxin [14], and diphtheria toxin [15]. It is possible
that during maturation, a furin-like protease hydrolyses
K-LTX, producing an active toxin. Still, the cleavage of
K-LTX precursor at the N-terminus cannot account for a
protein of 130 kDa. Therefore, another proteolytic site should
be located in the C-terminal part of the protoxin. In fact,
another potential furin site (K-F-R-R) has been found in
the C-terminal region of the precursor. Proteolysis at both
sites would produce a protein of exactly 131.5 kDa, which
is very close to the estimated molecular mass of the natural
toxin. Therefore, a fragment of K-LTX cDNA (encompassing
base pairs 142^3679, which encode amino acids 1^1179 be-
tween the two putative cleavage sites) was used to construct
the recombinant vector.
Construction of the transfer plasmid pMelBac-K-LTX-M is
schematically shown in Fig. 1. Overlapping K-LTX cDNA
clones [7] were linked together (see Section 2) and then used
as a template to PCR-amplify the sequence between base pairs
142 and 3679. PCR primers L01 and L08R were designed to
introduce appropriate restriction sites and a stop codon at the
3P end. The resulting cDNA fragment was introduced into the
baculovirus transfer vector pMelBacA in frame with the me-
littin signal peptide under the control of the polyhedrin pro-
moter. This exogenous signal peptide was used to facilitate
secretion of recombinant K-LTX that lacks its own signal
sequence. After co-transfection of Sf9 cells with pMelBac-K-
LTX-M and baculoviral DNA, six recombinant plaques were
selected. The titre of ¢nal stocks of ampli¢ed recombinant
viruses reached 1^3U108 pfu/ml.
3.2. Expression and puri¢cation of recombinant K-LTX
The cabbage looper cell line Hi5, which is known to express
secreted proteins more e⁄ciently than Sf9 or Sf21 cell lines
[16], was used to produce K-LTX. First, to optimise the yield
of expressed recombinant toxin, we determined an optimal
combination of two parameters: expression time and MOI.
Hi5 cells were infected at MOI 1, 5, 10 or 20 pfu/cell and
aliquots of the media collected 24, 48, 72 and 96 h after in-
fection. Samples were analysed by immunoblotting using anti-
bodies against K-LTX (data not shown). It was found that the
secreted recombinant toxin reached a maximum of about
1 Wg/ml in the culture medium 72^96 h post infection, whilst
the optimal MOI was 10 pfu/cell. For large-scale expression,
the cells were infected using 10 pfu/cell. One day following
infection, the medium was changed to remove serum proteins,
thus simplifying K-LTX puri¢cation. This did not a¡ect the
level of the toxin production, since at this time most of the
live viruses in the medium had infected the cells and secretion
of K-LTX had not yet started.
Puri¢cation of recombinant toxin was carried out using a
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Fig. 1. The structure of K-LTX and construction of a recombinant vector for the toxin expression using baculovirus. A: The coding (open
box) and untranslated regions of the K-LTX cDNA. B: Domain structure of the K-LTX precursor. I, leader sequence; II, N-terminal domain;
III, central domain containing 22 ankyrin repeats; IV, C-terminal domain. Hatched domains are absent from the mature protein. C: Overlap-
ping K-LTX cDNA clones. These were cleaved and re-ligated at the EcoRI restriction site to produce a continuous template for PCR. Letters
above denote positions of recognition sites for restrictases BamHI (B), EcoRI (E), HpaII (H), and SalI (S). D: PCR ampli¢cation of the
cDNA fragment encoding mature K-LTX. The upstream and downstream primers were designed to anneal at the ends of the sequence encoding
the mature protein and to introduce restriction sites and a stop codon. E: The structure of recombinant K-LTX. The PCR-ampli¢ed DNA
fragment was cut with BamHI and SalI and ligated in frame with the melittin signal peptide (SP) of pMelBac vector cleaved with the same en-
zymes. The arrow marks the position of post-translational cleavage of the recombinant protein by insect cells, resulting in the mature toxin
(K-LTX-M). The scale bar (in base pairs) is shown at the top.
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three-stage procedure. Initially, it was necessary to raise the
pH of the medium; this allowed the toxin to bind to the anion
exchangers used later. At the next stage, the preparation was
passed through an anion-exchange ¢lter, which adsorbed all
recombinant toxin and some contaminating proteins (Fig. 2).
This gave approximately 10-fold enrichment of the toxin. Fi-
nally, K-LTX was further puri¢ed by high-pressure anion-
exchange liquid chromatography. Like the natural toxin, re-
combinant K-LTX eluted from the column at 0.3^0.4 M
NaCl. The toxin-containing fractions were combined and con-
centrated by ultra¢ltration (Fig. 2). Judging by SDS electro-
phoresis, the purity of the ¢nal toxin preparation was 40^50%.
Since the total protein concentration in this sample was
0.7 mg/ml, the estimated concentration of K-LTX appeared
to be 0.25 mg/ml. Thus, the yield of the puri¢ed toxin was
0.2^0.3 mg/l of cell culture medium.
3.3. Biological activity of expressed K-LTX
The recombinant toxin was highly toxic to mice; its LD100
of less than 170 Wg/kg body weight was comparable to that of
the natural K-LTX [17]. One of the main features of K-LTX is
its ability to cause a dramatic increase in the frequency of
spontaneous quantal release from nerve terminals in verte-
brates [18]. To investigate whether the recombinant toxin pos-
sesses the same functional activity, we studied its e¡ect on the
frequency of MEPPs in mouse nerve-muscle preparations.
A typical experiment is shown in Fig. 3. Under our experi-
mental conditions MEPPs occurred at a rate of about 0.5^
0.7 MEPPs/s in resting nerve-muscle preparations (n = 5). Fol-
lowing bath application of 3^5 nM of recombinant K-LTX,
MEPP frequency started increasing after a delay of 20^30
min. Maximal e¡ect was achieved 40^50 min after the toxin
application, reaching 80^100 MEPPs/s (n = 5). The MEPP fre-
quency then gradually decreased indicating the depletion of
neurotransmitter stores in terminals. These results demon-
strate that recombinant K-LTX is able to stimulate neuro-
transmitter release comparable to that evoked by the native
toxin.
K-LTX exerts its action at the nerve terminal after binding
to a speci¢c presynaptic receptor. To date, two potential toxin
receptors have been found, neurexin IK and latrophilin [8,19^
21]. To elucidate whether recombinant K-LTX binds to these
receptors, we expressed latrophilin and neurexin in COS-7
cells, which do not normally bind the toxin. When transfected
cells were incubated with the culture medium containing the
recombinant toxin and then pelleted by centrifugation, K-LTX
co-precipitated only with those cells that expressed either of
these receptors but not with the control cells (Fig. 4). This
result indicated that the recombinant toxin bound speci¢cally
to both latrophilin and neurexin IK.
The recombinant toxin, thus, possesses all the properties of
natural K-LTX, suggesting that the latter is indeed proteo-
lysed at the putative furin sites during maturation in the black
widow spider venom glands.
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Fig. 3. Time course of the changes in MEPP frequency caused by
recombinant K-LTX at a single neuromuscular junction. K-LTX (4
nM) was bath-applied to a mouse diaphragm at time 0 and MEPPs
were recorded as described in Section 2. Each point represents val-
ues averaged over 2-min periods.
Fig. 4. Binding of recombinant K-LTX to latrophilin and neurexin
IK. COS-7 cells were transfected with vector, latrophilin or neurexin
cDNA as shown. After incubation in K-LTX-containing medium
(Medium), the cells were pelleted by centrifugation and analysed by
SDS gel electrophoresis and immunoblotting with antibodies to la-
trophilin (LPH), neurexin IK (NRX) or K-LTX (LTX). Recombi-
nant K-LTX from the medium bound speci¢cally only to the cells
that expressed either latrophilin or neurexin IK.
Fig. 2. Puri¢cation of K-LTX from culture medium. Cell culture
medium (Medium) was concentrated on anion-exchange ¢lter and
eluted with 1 M NaCl (‘Q-¢lter eluate’). Anion-exchange chroma-
tography of this eluate on a Mono-Q column, eluted with a linear
gradient of NaCl, produced a fraction containing recombinant K-
LTX (‘Mono-Q’). Samples taken after each puri¢cation step were
analysed by SDS gel electrophoresis and Western blotting with an
anti-K-LTX antibody using enhanced luminescence detection.
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This paper describes a novel method for functional expres-
sion of K-LTX based on the use of baculovirus system1. The
problem of producing an active, soluble form of the toxin was
solved by introducing a strong signal peptide at the N-termi-
nus of the toxin and by the removal of its C-terminus, whose
presence renders the toxin inactive. This approach will allow
us to carry out mutational analysis of K-LTX functional do-
mains.
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